| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R Klink, A de Kerchove d'Exaerde, M Zoli, J P Changeu. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 21. issue 5. 2001-04-05. PMID:11222635. |
molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. |
2001-04-05 |
2023-08-12 |
mouse |
| H Katsuki, M Tomita, C Takenaka, H Shirakawa, S Shimazu, M Ibi, T Kume, S Kaneko, A Akaik. Superoxide dismutase activity in organotypic midbrain-striatum co-cultures is associated with resistance of dopaminergic neurons to excitotoxicity. Journal of neurochemistry. vol 76. issue 5. 2001-04-05. PMID:11238718. |
we have previously demonstrated that dopaminergic neurons in midbrain-striatum slice co-cultures are more resistant to nmda cytotoxicity than the same neuronal population in single midbrain slice cultures. |
2001-04-05 |
2023-08-12 |
Not clear |
| C Perrone-Capano, U Di Porzi. Genetic and epigenetic control of midbrain dopaminergic neuron development. The International journal of developmental biology. vol 44. issue 6. 2001-03-29. PMID:11061432. |
a number of laboratories, including ours, have contributed to unravel the mechanisms of da phenotype induction and maturation and elucidated the role of epigenetic factors involved in specification, development and maintenance of midbrain dopaminergic functions. |
2001-03-29 |
2023-08-12 |
Not clear |
| N A Muma, J M Lee, L Gorman, B A Heidenreich, I Mitrovic, T C Napie. 6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins. Experimental neurology. vol 168. issue 1. 2001-03-29. PMID:11170728. |
the 6-hydroxydopamine injections robustly reduced the number of monoaminergic cell bodies in the lateral midbrain and dramatically decreased dopamine and its major metabolites in dopaminergic projection sites. |
2001-03-29 |
2023-08-12 |
rat |
| V Seutin, L Massotte, M F Renette, A Dress. Evidence for a modulatory role of Ih on the firing of a subgroup of midbrain dopamine neurons. Neuroreport. vol 12. issue 2. 2001-03-29. PMID:11209930. |
a previous investigation has suggested that the hyperpolarization-activated cation current ih does not contribute to the spontaneous firing of midbrain dopaminergic neurons. |
2001-03-29 |
2023-08-12 |
Not clear |
| V Seutin, L Massotte, M F Renette, A Dress. Evidence for a modulatory role of Ih on the firing of a subgroup of midbrain dopamine neurons. Neuroreport. vol 12. issue 2. 2001-03-29. PMID:11209930. |
we conclude that ih controls to a certain extent the firing of a majority of midbrain dopaminergic neurons. |
2001-03-29 |
2023-08-12 |
Not clear |
| I Fried, C L Wilson, J W Morrow, K A Cameron, E D Behnke, L C Ackerson, N T Maidmen. Increased dopamine release in the human amygdala during performance of cognitive tasks. Nature neuroscience. vol 4. issue 2. 2001-03-22. PMID:11175882. |
the amygdala is a major target of midbrain dopaminergic neurons and is implicated in learning and memory processes, particularly those involving associations between novel stimuli and reward. |
2001-03-22 |
2023-08-12 |
human |
| D C German, C L Liang, K F Manaye, K Lane, P K Sonsall. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons. Neuroscience. vol 101. issue 4. 2001-03-01. PMID:11113355. |
pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons. |
2001-03-01 |
2023-08-12 |
mouse |
| T Yamamoto, K Takad. Role of cannabinoid receptor in the brain as it relates to drug reward. Japanese journal of pharmacology. vol 84. issue 3. 2001-03-01. PMID:11138722. |
the involvement of the cb1 receptor in mediating reinforcing and physical dependence-producing effects of opioids has also been suggested, with the former being considered the result of interaction with the dopaminergic neurotransmission in the midbrain dopamine system. |
2001-03-01 |
2023-08-12 |
Not clear |
| B Reuss, K Unsicke. Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells. Molecular and cellular neurosciences. vol 16. issue 6. 2001-02-22. PMID:11124897. |
survival of dopaminergic (daergic) midbrain neurons during development and after lesioning depends, in part, on the presence of astroglia-derived growth factors, as, e.g., fibroblast growth factor (fgf)-2. |
2001-02-22 |
2023-08-12 |
rat |
| J Witta, J S Baffi, M Palkovits, E Mezey, S O Castillo, V M Nikode. Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation. Brain research. Molecular brain research. vol 84. issue 1-2. 2001-02-15. PMID:11113533. |
the untranslated exon 1-2 of the nurr1 gene, which remains intact after homologous recombination, revealed the presence of dopaminergic precursors in the ventral midbrain of the nurr1-null mice. |
2001-02-15 |
2023-08-12 |
mouse |
| J Witta, J S Baffi, M Palkovits, E Mezey, S O Castillo, V M Nikode. Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation. Brain research. Molecular brain research. vol 84. issue 1-2. 2001-02-15. PMID:11113533. |
these results provide evidence that nurr1 is essential for terminal differentiation of the dopaminergic neurons in the ventral midbrain but does not affect the early steps of their neurogenesis, migration, survival and striatal projections. |
2001-02-15 |
2023-08-12 |
mouse |
| M Barrot, L Calza, M Pozza, M Le Moal, P V Piazz. Differential calbindin-immunoreactivity in dopamine neurons projecting to the rat striatal complex. The European journal of neuroscience. vol 12. issue 12. 2001-02-15. PMID:11122372. |
after iontophoretic injections of fluoro-gold in the dopaminergic terminal fields, the presence of tyrosine hydroxylase and calbindin were immunohistochemically assessed in the mesencephalon. |
2001-02-15 |
2023-08-12 |
rat |
| M Melis, G L Gessa, M Dian. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain. Progress in neuro-psychopharmacology & biological psychiatry. vol 24. issue 6. 2001-02-08. PMID:11041539. |
different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain. |
2001-02-08 |
2023-08-12 |
rat |
| J Carlson, B Armstrong, R C Switzer, G Elliso. Selective neurotoxic effects of nicotine on axons in fasciculus retroflexus further support evidence that this a weak link in brain across multiple drugs of abuse. Neuropharmacology. vol 39. issue 13. 2001-02-08. PMID:11044749. |
when administered continuously for several days at relatively low plasma levels, a variety of drugs of abuse with strong dopaminergic actions induce degeneration in axons traveling from the lateral habenula through the sheath of fasciculus retroflexus to midbrain monoaminergic nuclei. |
2001-02-08 |
2023-08-12 |
Not clear |
| J Strelau, A Sullivan, M Böttner, P Lingor, E Falkenstein, C Suter-Crazzolara, D Galter, J Jaszai, K Krieglstein, K Unsicke. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 20. issue 23. 2001-02-08. PMID:11102463. |
growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. |
2001-02-08 |
2023-08-12 |
rat |
| J Strelau, A Sullivan, M Böttner, P Lingor, E Falkenstein, C Suter-Crazzolara, D Galter, J Jaszai, K Krieglstein, K Unsicke. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 20. issue 23. 2001-02-08. PMID:11102463. |
gdf-15/mic-1 is a potent survival promoting and protective factor for cultured and iron-intoxicated dopaminergic (daergic) neurons cultured from the embryonic rat midbrain floor. |
2001-02-08 |
2023-08-12 |
rat |
| J Yan, L Studer, R D McKa. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. Journal of neurochemistry. vol 76. issue 1. 2001-02-08. PMID:11146004. |
cns precursors derived from e12 rat mesencephalon proliferate in the presence of basic fibroblast growth factor and differentiate in vitro into functional dopaminergic neurons, which upon transplantation alleviate behavioral symptoms in a rat model of parkinson's disease. |
2001-02-08 |
2023-08-12 |
rat |
| Y Fu, S G Matta, W Gao, B M Shar. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo. Neuroscience. vol 101. issue 2. 2001-02-01. PMID:11074160. |
in conclusion, the present study demonstrates that different types of nicotinic cholinergic receptors, located in the ventral striatal nucleus accumbens (alpha-bungarotoxin sensitive and mecamylamine insensitive) and the midbrain ventral tegmental area (mecamylamine sensitive), may be required for the full effects of nicotine on the mesostriatal dopaminergic pathway. |
2001-02-01 |
2023-08-12 |
Not clear |
| Z U Khan, A Gutiérrez, R Martín, A Peñafiel, A Rivera, A de la Call. Dopamine D5 receptors of rat and human brain. Neuroscience. vol 100. issue 4. 2001-01-18. PMID:11036203. |
the d5 antibody labeled dopaminergic neurons of mesencephalon, and cortical and subcortical structures. |
2001-01-18 |
2023-08-12 |
human |